Here's how they compare: Semaglutide (GLP-1 agonist) Mechanism: Single-action GLP-1 receptor agonist FDA status: Approved for type 2 diabetes and chronic weight management Expected weight loss: 15-20% of body weight in clinical trials Administration: Once-weekly injection Best for: Patients starting their weight loss journey seeking proven, well-studied medication Tirzepatide (dual GIP/GLP-1 agonist) Mechanism: Targets both GIP and GLP-1 receptors for enhanced metabolic effect FDA status: Approved for type 2 diabetes and chronic weight management Expected weight loss: Up to 22% of body weight in clinical trials Administration: Once-weekly injection Best for: Patients seeking more aggressive fat loss with dual-action metabolic support Retatrutide (triple agonist, not yet available) Mechanism: Targets GLP-1, GIP, and glucagon receptors FDA status: Not FDA-approved
She had lost 21 kg one month after the initiation of tirzepatide
Its also important to remember that ED can have many different causes, from blood flow and hormones to stress or medical conditions and natural adjuncts like Mucuna Pruriens for ED may be discussed alongside clinical care
PlexusDx offers compounded semaglutide injection at $189/mo month-to-month, or from $149/mo on the 6-month plan and compounded tirzepatide injection at $289/mo month-to-month, or from $249/mo on the 6-month plan, with the flexibility to adjust formulations based on your tolerance and response
New England Journal of Medicine, 387(1), 109119
More This is a great place to provide infusion therapy they do their own pharmaceuticals compounding for semaglutide and Tirzepatude as well as vitamine infusions
